LEONID METELITSA to Cancer Vaccines
This is a "connection" page, showing publications LEONID METELITSA has written about Cancer Vaccines.
Connection Strength
0.653
-
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy. Blood. 2014 Oct 30; 124(18):2824-33.
Score: 0.329
-
Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist. Org Biomol Chem. 2019 01 31; 17(5):1225-1237.
Score: 0.113
-
Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system. Cancer Res. 2014 Nov 01; 74(21):6260-70.
Score: 0.083
-
Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors. Cancer Res. 2011 Jun 15; 71(12):4183-91.
Score: 0.066
-
Novel cancer vaccine based on genes of Salmonella pathogenicity island 2. Int J Cancer. 2010 Jun 01; 126(11):2622-34.
Score: 0.062